Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1992-10-8
|
pubmed:abstractText |
We performed a randomized, double-blind, controlled trial to determine whether vitamin A supplementation in a group of very low birth weight infants would reduce the incidence of bronchopulmonary dysplasia. Forty-nine infants (birth weight 700 to 1100 gm) requiring mechanical ventilation and supplemental oxygen at 96 hours age were randomly assigned to receive either 2000 IU retinyl palmitate (n = 27) or saline placebo (n = 22) intramuscularly every other day for up to 14 doses. There were no differences between treatment groups in the incidences of bronchopulmonary dysplasia at 31 days of postnatal age (vitamin A group 48%, placebo group 55%; p = 0.776), supplemental oxygen requirement at 34 weeks of postconceptional age, or other complications of prematurity. The vitamin A group had higher mean plasma vitamin A concentrations than the placebo group, but mean plasma vitamin A concentrations were greater than 20 micrograms/dl (suggesting sufficiency) in both groups after the first study week. By study day 28, only one fourth of the infants in either group had plasma vitamin A concentrations less than 20 micrograms/dl. In contrast to an earlier report, we found no change in the incidence of BPD with vitamin A supplementation. Our findings may reflect a low baseline incidence of vitamin A deficiency in the study population and recent changes in the respiratory care of very low birth weight infants. The latter may have lessened the potential impact of vitamin A deficiency on lung disease.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-3476
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
420-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1517921-Bronchopulmonary Dysplasia,
pubmed-meshheading:1517921-Diet,
pubmed-meshheading:1517921-Double-Blind Method,
pubmed-meshheading:1517921-Female,
pubmed-meshheading:1517921-Humans,
pubmed-meshheading:1517921-Incidence,
pubmed-meshheading:1517921-Infant, Low Birth Weight,
pubmed-meshheading:1517921-Infant, Newborn,
pubmed-meshheading:1517921-Male,
pubmed-meshheading:1517921-Oxygen Inhalation Therapy,
pubmed-meshheading:1517921-Risk Factors,
pubmed-meshheading:1517921-Treatment Outcome,
pubmed-meshheading:1517921-Vitamin A
|
pubmed:year |
1992
|
pubmed:articleTitle |
Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia.
|
pubmed:affiliation |
Department of Pediatrics, University of North Carolina Hospital, Chapel Hill 27599-7596.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|